Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06861933

The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease

With this study, individuals diagnosed with PD in Burdur province in Turkey will be provided with a physiotherapy and rehabilitation program for the upper extremity, and it is thought that the treatment received by both groups will have a positive effect on the functionality of the individuals. According to the results of our study, it will be determined whether the scapula kinematics and upper extremity functionality of individuals diagnosed with PD are different from healthy individuals of the same age and gender. After the intervention programs applied to the individuals, it is thought that it will contribute to the physiotherapy and rehabilitation programs of individuals with PD by determining whether the scapulohumeral rehabilitation program is superior to the upper extremity neurorehabilitation program.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Burdur Mehmet Akif Ersoy University, Burdur, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • For the intervention group:
  • Having been diagnosed with Parkinson's Disease
  • Being between 1-3 according to the Hoehn & Yahr staging
  • For the control group:
  • Being of the same age and gender as the individuals diagnosed with Parkinson's disease included in the study

Exclusion criteria

  • For the intervention group:
  • Refusing to participate in the study
  • Having a full-thickness rotator cuff muscle rupture
  • Having a history of humerus, clavicle, scapula or shoulder surgery
  • Having a history of humerus, clavicle, scapula or shoulder fracture
  • Having a history of any other disease that may affect the ability to stand independently
  • For the control group:
  • Refusing to participate in the study
  • Having a full-thickness rupture of the rotator cuff muscles
  • Having a history of humerus, clavicle, scapula or shoulder surgery
  • Having a history of humerus, clavicle, scapula or shoulder fracture

Study Exclusion Criteria for Volunteers:

  • Failure to complete the tests included in the study
  • Failure to comply with the study schedule, failure to complete sessions
  • Incomplete data
  • Failure to attend 3 consecutive sessions
  • Voluntary withdrawal

Treatment and study plan

Physiotherapy and rehabilitation

Other

It is reported in the literature that scapulohumeral rehabilitation applied in primary shoulder pathologies is effective. In neurological diseases, a study was found in which scapulohumeral rehabilitation was applied to individuals diagnosed with stroke and reported that it was effective. However, when the literature was examined, no study was found in which scapulohumeral rehabilitation was applied to individuals diagnosed with PD. Therefore, our aim is to compare the effectiveness of the scapulohumeral rehabilitation program to be applied for shoulder dysfunction, which is thought to be one of the early findings in PD and is reported to be related to other main findings in PD, with the upper extremity neurorehabilitation program.

Other names: Physiotherapy, Rehabilitation, neurorehabilitation

Primary outcomes

  1. Scapular Index

    Time frame: From enrollment to the end of treatment at 7 weeks

    It is calculated with the formula (distance between sternal notch - coracoid process / posterolateral angle of acromion - horizontal distance between thoracic spine) x 100.

  2. Pectoralis Minor Index

    Time frame: From enrollment to the end of treatment at 7 weeks

    It is calculated with the formula Pectoralis Minor Index = (Pectoralis Minor Length / Participant's height) x 100.

  3. Lateral Scapular Slide Test

    Time frame: From enrollment to the end of treatment at 7 weeks

    In the Lateral Scapular Slide Test, the distance to the thoracic spinous process corresponding to the inferior angle of the scapula is measured in three different positions: arms relaxed at the sides, hands on the iliac crest, and arm in 90-degree shoulder abduction and full internal rotation. The distances between the two sides are compared. A difference of more than 1.5 cm between the two sides is considered asymmetric.

  4. Box and Block Test

    Time frame: From enrollment to the end of treatment at 7 weeks

    150 small wooden cubes are filled from the box where the patient's hand is to be tested to the box next to it. The patient is asked to throw one cube at a time into the empty box next to it. The number of cubes thrown in 60 seconds is counted. The result gives the score. The test is repeated for both hands.

  5. Upper Extremity Functional Index

    Time frame: From enrollment to the end of treatment at 7 weeks

    It is a scale developed by Stratford et al. in 2001 and consists of twenty activity questions. The person scores between 0-4 according to the difficulty of doing the activity. The lowest score in total is 0, the highest score is 80. Low scores indicate that the person has difficulty doing the activity due to the condition of the upper extremity.

  6. Ultrasound

    Time frame: From enrollment to the end of treatment at 7 weeks

    During the evaluation, the patient will be in a sitting position, with the arm next to the body, the forearm in supination and the elbow in full extension. Supraspinatus muscle thickness measurement will be performed by positioning the probe on the fossa supraspinata of the scapula, perpendicular to the skin, along the muscle fibers. The hyperechogenic bone cortex of the fossa supraspinata will be accepted as the landmark. When the muscle fibers are visualized, the thickness of the supraspinatus muscle will be measured from the level where the muscle is observed to be thickest. For the infraspinatus muscle thickness measurement, the hyperechogenic bone cortex of the fossa infraspinata of the scapula will be accepted as the landmark, and the probe will be placed perpendicular to the skin, along the muscle fibers. After the muscle fibers are visualized, the thickness of the infraspinatus muscle will be measured from the level where the muscle is observed to be thickest.

Secondary outcomes

  1. Visual Analog Scale (VAS)

    Time frame: From enrollment to the end of treatment at 7 weeks

    VAS is a 10-centimeter (cm) scale where 0 is defined as "no pain" and 10 is defined as "unbearable pain". It is a valid and reliable method for assessing the severity of musculoskeletal pain and is frequently used in clinical studies. In a study conducted on patients with chronic musculoskeletal pain, VAS values less than 3.4 cm were classified as mild pain, VAS values between 3.5 and 7.4 cm were classified as moderate pain, and VAS values greater than 7.5 cm were classified as severe pain. The participants' pain severity will be assessed with VAS for resting and activity conditions.

  2. King's Parkinson's Pain Scale

    Time frame: From enrollment to the end of treatment at 7 weeks

    Consists of 14 items divided into seven different areas. Each item is scored by multiplying the severity (0 [no pain] 3 [very severe pain]) (0 [never] 4 [always]). The areas and score ranges are: musculoskeletal pain (0-12 points); chronic pain (0-24 points); pain associated with fluctuation (0-36 points); night pain (0-24 points); orofacial pain (0-36 points); color change, edema (0-24 points); radicular pain (0-12 points).

  3. Range of Motion

    Time frame: From enrollment to the end of treatment at 7 weeks

    Participants' shoulder flexion, abduction, internal and external rotation movements will be evaluated with a manual goniometer. The angle at which shoulder pain develops in active and passive movements will be recorded.

  4. Scapula Angles

    Time frame: From enrollment to the end of treatment at 7 weeks

    The scapula will be evaluated with the inclinometer in three different positions: at rest, with the shoulder at 45 degrees of flexion and 90 degrees of flexion. The difference between the right and left sides will be compared.

  5. New York Posture Rating Chart

    Time frame: From enrollment to the end of treatment at 7 weeks

    Postural changes in 13 different body segments based on observation are scored as 1 point (marked deviation), 3 points (slight deviation), or 5 points (correct posture). The total score ranges from 13 to 65 points, with higher scores indicating correct/normal postural alignment.

  6. PostureScreen Mobile Smartphone Application

    Time frame: From enrollment to the end of treatment at 7 weeks

    It is an image-based method that takes photographs of individuals in the sagittal and frontal planes. The application calculates postural variables using the individual's anatomical points that are digitally marked depending on the number of variables of interest. This process of digitally marking the points consists of drawing the boundaries of anatomical reference points (pelvic iliac crests, greater trochanter, femoral condyle, and ear lobule) directly on the mobile device screen. Body angles are then calculated. As a result, it provides an output file containing the values of the postural variables and images showing the digitized points and their positions relative to a neutral posture.

Sponsors and collaborators

Lead sponsor

Burdur Mehmet Akif Ersoy University

Other

Collaborators

  • Pamukkale University

Registry information

Official study title

The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease: A Single Blind Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 6, 2025
Registry last updated
Sep 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.